Log In
BCIQ
Print this Print this
 

Fostrap

  Manage Alerts
Collapse Summary General Information
Company Nestle S.A.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHyperphosphatemia
Indication DetailsTreat hyperphosphatemia in patients with chronic kidney disease (CKD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today